U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07111247) titled 'Insights in Endocervical Mucus Secretion' on July 28.
Brief Summary: Single arm interventional study looking at biological outcomes at 4 time points throughout the cycle before and after taking an oral gonadotropin-releasing hormone antagonist (gnRH). Samples of whole blood, endocervical mucus, endocervical biopsy, and vaginal swab will be collected.
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Cervical Mucus
Intervention:
DRUG: Gonadotropin Releasing Hormone Antagonists Relugolix
Gonadotropin releasing hormone antagonist (gnRH) taken for 10 days starting during the midluteal phase.
Recruitment Status: N...